Increased tumor cell death was observed following combination treatment and, in addition, the enzymatic dissociation of PCTS and subsequent flow cytometric analysis showed the increased presence of CD45+, CD8+ and CD4+ T cells after treatment combination [52]. The gene discussed is CD4; the disease is neoplasm.